CStone Raises $260 million in Series B Financing to Advance Novel Cancer Therapies
SUZHOU, China, May 9, 2018 /PRNewswire/ — CStone Pharmaceuticals (“CStone”) announced today the successful completion of a $260 million (about RMB1.65 billion) financing, the largest Series B funding in the…